Sakar Healthcare Limited (SAKAR) — Financial Results | 13 June 2026

· NSE ✨ Positive
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings

Sakar Healthcare Limited reported consolidated revenue of ₹7126.82 crores and profit after tax of ₹1102.43 crores for the year ended March 31, 2026, reflecting robust growth from prior periods, with earnings per share at ₹4.96. The audited financials, approved on May 12, 2026, include an unmodified auditor's opinion and compliance with Ind AS and listing regulations. No material changes or forward guidance were disclosed, and the company maintains a stable financial position with no material uncertainties.

📄 View Original Announcement (PDF)

About Sakar Healthcare Limited (SAKAR)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹1,550.15 Cr P/E: 102.3

View full SAKAR stock details →

📡 Get AI alerts when SAKAR files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track SAKAR — Free

📊 More SAKAR filings

See all SAKAR filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when SAKAR files new disclosures

Track SAKAR filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track SAKAR — Free

Free account · 2 AI queries/day